ES2197618T3 - Agentes antiinflamatorios con selectividad glucocorticoide. - Google Patents
Agentes antiinflamatorios con selectividad glucocorticoide.Info
- Publication number
- ES2197618T3 ES2197618T3 ES99905971T ES99905971T ES2197618T3 ES 2197618 T3 ES2197618 T3 ES 2197618T3 ES 99905971 T ES99905971 T ES 99905971T ES 99905971 T ES99905971 T ES 99905971T ES 2197618 T3 ES2197618 T3 ES 2197618T3
- Authority
- ES
- Spain
- Prior art keywords
- carbon
- twelve carbons
- twelve
- alkyl
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229940121363 anti-inflammatory agent Drugs 0.000 title 1
- 239000002260 anti-inflammatory agent Substances 0.000 title 1
- 239000003862 glucocorticoid Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 7
- 229910052799 carbon Inorganic materials 0.000 abstract 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 6
- 125000003118 aryl group Chemical group 0.000 abstract 5
- 239000011203 carbon fibre reinforced carbon Substances 0.000 abstract 4
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 229910052757 nitrogen Inorganic materials 0.000 abstract 4
- 229910052760 oxygen Inorganic materials 0.000 abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 229910052717 sulfur Inorganic materials 0.000 abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 2
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 229920001774 Perfluoroether Polymers 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cephalosporin Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Un compuesto de la Fórmula I **FORMULA** donde el símbolo- - - - - representa un enlace sencillo o doble, siempre que dos dobles enlaces no estén en posiciones contiguas; R1, R2, R3 y R4 son cada uno, independientemente, hidrógeno o E; o R1 y R2 juntos son -X*-Y*-Z*- donde * X* s es -O-o -CH2-, Y* es -C(O)- o - (C(R12)(R13))v donde R12 y R13 son, independientemente, hidrógeno o alquilo de uno a doce carbonos, y v es 1, 2 ó 3, y Z* se selecciona de -CH2-, -CH2S(O)t- donde t, como se utiliza aquí, es 0, 1 ó 2, -CH2O-, -CH2NR7- donde R7 se define abajo, - NR7- donde R7 se define abajo, y -O-; E es -LE-RE donde LE se selecciona de (1) un enlace covalente, (2) -O-, (3) -S(O)t-, (4) -C(X)-, donde X, como se utiliza aquí, se selecciona de O o S, (5) -NR7-, ; donde R7, como se utiliza aquí, se selecciona de (a) hidrógeno, (b) arilo (c) cicloalquilo de tres a doce carbonos, (d) alcanoílo, donde la parte alquilo es de uno a doce carbonos, (e) alcoxicarbonilo, donde la parte alquilo es de uno a doce carbonos, (f) alcoxicarbonilo, donde la parte alquilo es de uno a doce carbonos y está sustituida por 1 ó 2 grupos arilo, (g) alquilo de uno a doce carbonos, (h) alquilo de uno a doce carbonos sustituido con 1 ó 2 sustituyentes seleccionados, independientemente, de arilo o cicloalquilo de tres a doce carbonos, (i) alquenilo de tres a doce carbonos, siempre que un carbono de un doble enlace carbono-carbono no esté unidodirectamente a nitrógeno, (j) alquinilo de tres a doce carbonos, siempre que un carbono de un triple enlace carbono-carbono no esté unidodirectamente a nitrógeno, (6) -NR8C(X)NR9-, donde R8 y R9, como se utiliza aquí, son seleccionados, independientemente, de (a) hidrógeno, (b) arilo, (c) cicloalquilo de tres a doce carbonos, (d) alquilo de uno a doce carbonos, (e) alquilo de uno a doce carbonos sustituido con 1 ó 2 sustituyentes seleccionados, independientemente, de arilo o cicloalquilo de tres a doce carbonos, (f) alquenilo de tres a doce carbonos, siempre que un carbono de un doble enlace carbono-carbono no esté unido directamente a nitrógeno, alquinilo de tres a doce carbonos, siempre que un carbono de un triple enlace carbono-carbono no esté unido directamente a nitrógeno, (7) -X¿C(X)- donde X¿, como se utiliza aquí, se selecciona de O o S, (8) -C(X)X¿-, (9) -X¿C(X)X¿-, donde X¿, como se utiliza aquí, se selecciona de O o S, siempre que cuando X sea O, al menos uno de X¿ o X¿ sea O, (10) -NR8C(X)-, 25 (11) -C(X)NR8-, (12) -NR8C(X)X¿-, (13) -X¿C(X)NR8-, (14) -SO2NR8-, (15) -NR8SO2-, y (16) -NR8SO2NR9donde (6)-(16) están dibujados con sus extremos derechos unidos a RE, y RE se selecciona de (1) -OH, (2) -OG, donde G es un grupo protector de -OH, (3) -SH, (4) -CN, (5) halo, (6) haloalcoxi de uno a doce carbonos, (7) perfluoroalcoxi de uno a doce carbonos, (8) -CHO, (9) -NR7R7, , donde R7, , como se utiliza aquí, se selecciona de
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/023,913 US6380207B2 (en) | 1998-02-13 | 1998-02-13 | Glucocortiocoid-selective antiinflammatory agents |
| US23913 | 1998-02-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2197618T3 true ES2197618T3 (es) | 2004-01-01 |
Family
ID=21817891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES99905971T Expired - Lifetime ES2197618T3 (es) | 1998-02-13 | 1999-02-15 | Agentes antiinflamatorios con selectividad glucocorticoide. |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6380207B2 (es) |
| EP (1) | EP1053240B1 (es) |
| JP (1) | JP2002503666A (es) |
| KR (1) | KR20010040940A (es) |
| CN (1) | CN1153771C (es) |
| AT (1) | ATE237620T1 (es) |
| AU (1) | AU760511B2 (es) |
| BG (1) | BG64213B1 (es) |
| BR (1) | BR9907847A (es) |
| CA (1) | CA2320911A1 (es) |
| DE (1) | DE69906938T2 (es) |
| DK (1) | DK1053240T3 (es) |
| ES (1) | ES2197618T3 (es) |
| HK (1) | HK1033309A1 (es) |
| HU (1) | HUP0100846A3 (es) |
| IL (1) | IL137509A0 (es) |
| NO (1) | NO20004052L (es) |
| NZ (1) | NZ506012A (es) |
| PL (1) | PL342999A1 (es) |
| PT (1) | PT1053240E (es) |
| SK (1) | SK284076B6 (es) |
| TR (1) | TR200002345T2 (es) |
| WO (1) | WO1999041257A1 (es) |
| ZA (1) | ZA99533B (es) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6566372B1 (en) * | 1999-08-27 | 2003-05-20 | Ligand Pharmaceuticals Incorporated | Bicyclic androgen and progesterone receptor modulator compounds and methods |
| ES2246292T3 (es) | 2000-10-30 | 2006-02-16 | Pfizer Products Inc. | Moduladores de receptor glucocorticoide. |
| US7026484B2 (en) * | 2001-02-23 | 2006-04-11 | Ligand Pharmaceuticals Incorporated | Tricyclic androgen receptor modulator compounds and methods |
| EP1467730A4 (en) | 2002-01-22 | 2010-03-10 | Univ California | Non-steroid ligands for the glucocorticoid receptor, compositions and uses thereof |
| KR100492913B1 (ko) * | 2002-08-23 | 2005-06-03 | 주식회사 태평양 | 피부 감작 및 자극을 완화하는 피부 외용제 조성물 |
| AU2003278744B2 (en) | 2002-08-28 | 2010-07-29 | Harbor Biosciences, Inc. | Therapeutic treatment methods |
| US20040220153A1 (en) * | 2002-09-24 | 2004-11-04 | Jost-Price Edward Roydon | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
| DE20301728U1 (de) * | 2002-10-11 | 2004-03-11 | Ligand Pharmaceuticals, Inc., San Diego | 5-substituierte 7,9-Difluor-5H-Chromeno(3,4-f) -Chinolin-Verbindungen als selektive Progesteronrezeptormodulator-Verbindungen |
| AU2003258047A1 (en) * | 2002-10-11 | 2004-05-04 | Ligand Pharmaceuticals Incorporated | 5-(1',1'-CYCLOALKYL/ALKENYL)METHYLIDENE 1,2-DIHYDRO-5H-CHROMENO(3,4-f)QUINOLINES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS |
| CA2500758A1 (en) * | 2002-10-11 | 2004-04-22 | Ligand Pharmaceuticals Incorporated | 5-cycloalkenyl 5h-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds |
| US7235662B2 (en) * | 2003-06-11 | 2007-06-26 | Bristol-Myers Squibb Company | Modulators of the glucocorticoid receptor and method |
| AU2004266160A1 (en) * | 2003-08-22 | 2005-03-03 | Ligand Pharmaceuticals Incorporated | 6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds |
| TW200517114A (en) | 2003-10-15 | 2005-06-01 | Combinatorx Inc | Methods and reagents for the treatment of immunoinflammatory disorders |
| DE602004031356D1 (de) | 2003-11-21 | 2011-03-24 | Zalicus Inc | Verfahren und reagenzien zur behandlung von entzündlichen erkrankungen |
| US8519158B2 (en) | 2004-03-12 | 2013-08-27 | Ligand Pharmaceuticals Incorporated | Androgen receptor modulator compounds and methods |
| KR101293935B1 (ko) * | 2005-06-17 | 2013-08-08 | 리간드 파마슈티칼스 인코포레이티드 | 안드로겐 수용체 조절 화합물 및 방법 |
| EP1916896A4 (en) | 2005-08-26 | 2010-08-11 | Univ California | NOT STEROID-antiandrogens |
| US8067433B2 (en) | 2005-11-09 | 2011-11-29 | Zalicus Inc. | Methods, compositions, and kits for the treatment of ophthalmic disorders |
| BRPI0619519A2 (pt) * | 2005-12-09 | 2011-10-04 | Hoffmann La Roche | compostos de propionamida como agentes antiinflamatórios |
| CN101326169B (zh) * | 2005-12-09 | 2011-11-16 | 霍夫曼-拉罗奇有限公司 | 作为抗炎剂的糖皮质激素受体调节剂 |
| US8269612B2 (en) | 2008-07-10 | 2012-09-18 | Black & Decker Inc. | Communication protocol for remotely controlled laser devices |
| US20100092479A1 (en) * | 2008-08-18 | 2010-04-15 | Combinatorx (Singapore) Pte. Ltd. | Compositions and methods for treatment of viral diseases |
| US9908182B2 (en) | 2012-01-30 | 2018-03-06 | Black & Decker Inc. | Remote programming of a power tool |
| US8919456B2 (en) | 2012-06-08 | 2014-12-30 | Black & Decker Inc. | Fastener setting algorithm for drill driver |
| US10011006B2 (en) | 2013-08-08 | 2018-07-03 | Black & Decker Inc. | Fastener setting algorithm for drill driver |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996019458A2 (en) | 1994-12-22 | 1996-06-27 | Ligand Pharmaceuticals Incorporated | Steroid receptor modulator compounds and methods |
| US5696127A (en) | 1994-12-22 | 1997-12-09 | Ligand Pharmaceuticals Incorporated | Steroid receptor modulator compounds and methods |
| US5693133A (en) | 1995-05-10 | 1997-12-02 | Akzo Nobel Nv | Asbestos free roof coatings |
-
1998
- 1998-02-13 US US09/023,913 patent/US6380207B2/en not_active Expired - Fee Related
-
1999
- 1999-01-25 ZA ZA9900533A patent/ZA99533B/xx unknown
- 1999-02-15 CN CNB998050342A patent/CN1153771C/zh not_active Expired - Fee Related
- 1999-02-15 EP EP99905971A patent/EP1053240B1/en not_active Expired - Lifetime
- 1999-02-15 DE DE69906938T patent/DE69906938T2/de not_active Expired - Fee Related
- 1999-02-15 PT PT99905971T patent/PT1053240E/pt unknown
- 1999-02-15 WO PCT/US1999/003210 patent/WO1999041257A1/en not_active Application Discontinuation
- 1999-02-15 CA CA002320911A patent/CA2320911A1/en not_active Abandoned
- 1999-02-15 HU HU0100846A patent/HUP0100846A3/hu unknown
- 1999-02-15 DK DK99905971T patent/DK1053240T3/da active
- 1999-02-15 KR KR1020007008857A patent/KR20010040940A/ko not_active Application Discontinuation
- 1999-02-15 TR TR2000/02345T patent/TR200002345T2/xx unknown
- 1999-02-15 PL PL99342999A patent/PL342999A1/xx unknown
- 1999-02-15 IL IL13750999A patent/IL137509A0/xx unknown
- 1999-02-15 SK SK1196-2000A patent/SK284076B6/sk unknown
- 1999-02-15 AU AU26003/99A patent/AU760511B2/en not_active Ceased
- 1999-02-15 BR BR9907847-3A patent/BR9907847A/pt not_active IP Right Cessation
- 1999-02-15 ES ES99905971T patent/ES2197618T3/es not_active Expired - Lifetime
- 1999-02-15 AT AT99905971T patent/ATE237620T1/de not_active IP Right Cessation
- 1999-02-15 NZ NZ506012A patent/NZ506012A/xx unknown
- 1999-02-15 JP JP2000531450A patent/JP2002503666A/ja not_active Withdrawn
-
2000
- 2000-08-11 NO NO20004052A patent/NO20004052L/no not_active Application Discontinuation
- 2000-08-17 BG BG104698A patent/BG64213B1/bg unknown
-
2001
- 2001-04-19 HK HK01102795A patent/HK1033309A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| TR200002345T2 (tr) | 2000-11-21 |
| EP1053240B1 (en) | 2003-04-16 |
| BG64213B1 (bg) | 2004-05-31 |
| ATE237620T1 (de) | 2003-05-15 |
| NO20004052D0 (no) | 2000-08-11 |
| PT1053240E (pt) | 2003-09-30 |
| HK1033309A1 (en) | 2001-08-24 |
| CN1297451A (zh) | 2001-05-30 |
| US20010049377A1 (en) | 2001-12-06 |
| EP1053240A1 (en) | 2000-11-22 |
| WO1999041257A1 (en) | 1999-08-19 |
| CN1153771C (zh) | 2004-06-16 |
| DE69906938T2 (de) | 2004-02-26 |
| PL342999A1 (en) | 2001-07-16 |
| NO20004052L (no) | 2000-10-12 |
| CA2320911A1 (en) | 1999-08-19 |
| AU2600399A (en) | 1999-08-30 |
| HUP0100846A2 (hu) | 2001-09-28 |
| AU760511B2 (en) | 2003-05-15 |
| SK284076B6 (sk) | 2004-09-08 |
| BR9907847A (pt) | 2001-01-09 |
| IL137509A0 (en) | 2001-07-24 |
| US6380207B2 (en) | 2002-04-30 |
| KR20010040940A (ko) | 2001-05-15 |
| NZ506012A (en) | 2003-03-28 |
| ZA99533B (en) | 1999-07-26 |
| HUP0100846A3 (en) | 2003-03-28 |
| JP2002503666A (ja) | 2002-02-05 |
| BG104698A (en) | 2001-05-31 |
| DE69906938D1 (de) | 2003-05-22 |
| SK11962000A3 (sk) | 2001-03-12 |
| DK1053240T3 (da) | 2003-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2197618T3 (es) | Agentes antiinflamatorios con selectividad glucocorticoide. | |
| ES2120535T3 (es) | Agentes reticulantes con trifuncionalidad de carbamato. | |
| ATE534709T1 (de) | Polymere farbstoffe für haare | |
| GT200300135A (es) | Derivados de indolinfenilsulfonamida | |
| ES2090567T3 (es) | Reticulante para lacas en polvo a base de poliesteres. | |
| ES2126499B1 (es) | Coiniciadores de borato para fotopolimerizacion. | |
| ES2186821T3 (es) | Derivados de 6- bencil- 2h-piridazin-3-ona, su preparacion y s u uso como inhibidores de la prostaglandin-g/h sintasa i y ii (cox i y cox ii). | |
| GT199900119A (es) | Jarabe antihistaminico estabilizado. | |
| ES2067466T5 (es) | Dispersante. | |
| ES2124997T3 (es) | Procedimiento para la preparacion de acido 5-formilvalerico y ester 5-formilvalerato. | |
| ES2070253T3 (es) | Ciclohexanoles sustituidos utiles como agentes para el sistema nervioso central. | |
| AR013693A1 (es) | Nuevas piperidinas y piperazinas como inhibidores de la agregacion plaquetaria | |
| ATE264268T1 (de) | Verfahren zur herstellung von zsm-5 und zsm-11 | |
| BR0110882A (pt) | Ligando bidentado, sistema catalisador, e, processo para a carbonilação de compostos etilenica ou acetilenicamente insaturados opcionalmente substituìdos | |
| ES2090938T3 (es) | Compuestos sulfonio seleccionados, idoneos en particular como iniciadores para la reticulacion termica de material polimerizable cationicamente. | |
| ES2118333T3 (es) | Derivados del acido naftilacetico como agonistas y antagonistas de pgez. | |
| ES2026669T3 (es) | Procedimiento para la preparacion y el uso terapeutico de los beta-d-fenil tioxilosidos. | |
| ES2009785B3 (es) | Procedimiento para preparar derivados de tioxantona. | |
| GT199900011A (es) | Nuevos derivados del acido dihidroxihexanoico | |
| ES2054318T3 (es) | Compuestos de piperidina-triacina para uso como estabilizadores para materiales organicos. | |
| ES2081314T3 (es) | Compuestos de diaminoetileno. | |
| GT199700118A (es) | Procedimiento para piridinas sustituidas. | |
| ES2132317T3 (es) | Isocianuratos prolongados para el uso como agentes de endurecimiento en composiciones de revestimiento. | |
| MX9307271A (es) | Derivados de 2-alcoxi-2 imidazolin-5-onas, procedimiento para su preparacion y composicion fungicida que los contiene. | |
| UY23682A1 (es) | Una composicion de resina fenolica que contiene fosfitos de arilo y metodo para su elaboracion |